Iranian Heart Journal

Iranian Heart Journal

Mitral Valve Papillary Fibroelastoma as an Incidental Finding in a 62-Year-Old Man: A Case Report

Document Type : Case Report

Authors
1 Cardio-Oncology Research Center, Rajaie Cardiovascular Medical and Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, IR Iran.
2 Department of Cardiology, Rajaie Cardiovascular Medical and Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, IR Iran.
3 Department of Cardiac Imaging, Rajaie Cardiovascular Medical and Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, IR Iran.
4 Department of Pathology, Rajaie Cardiovascular Medical and Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, IR Iran.
Abstract
Background: Primary cardiac tumors are rare, with the majority being benign. Papillary fibroelastoma (PFE) represents the third most common type of primary benign cardiac tumor. While most patients with PFEs remain asymptomatic, the condition is incidentally discovered in approximately one-third of cases. Nonetheless, some patients initially present with embolic events, such as stroke, transient ischemic attack, myocardial infarction, or symptoms of cardiac obstruction, including syncope, heart failure, or even death due to coronary ostial obstruction. Although PFEs are benign, they can pose life-threatening risks if they lead to valve obstruction or systemic embolization.
 
Case Presentation: A 62-year-old man was evaluated for exertional dyspnea (functional class II) and found to have a large, well-defined, round, hypermobile echo-dense mass attached to the ventricular side of the anterior mitral valve leaflet. Pathological examination confirmed the diagnosis of PFE.
 
Conclusions: Given that PFEs are relatively common tumors, they should be included in the differential diagnosis of cardiac masses. Despite their benign nature, urgent surgical resection is not only lifesaving but also critical in preventing tumor-related vascular, embolic, or neurological complications. (Iranian Heart Journal 2025; 26(2): 88-96)
Keywords

  1. Smajlović D. Strokes in young adults: epidemiology and prevention. Vasc Health Risk Manag. 2015; 11:157–64.
  2. Edwards FH, Hale D, Cohen A, Thompson L, Pezzella AT, Virmani R. Primary cardiac valve tumors. Ann Thorac Surg. 1991; 52:1127–31.
  3. Tamin SS, Maleszewski JJ, Scott CG, Khan SK, Edwards WD, Bruce CJ, Oh JK, Pellikka PA, Klarich KW. Prognostic and Bioepidemiologic Implications of Papillary Fibroelastomas. J Am Coll Cardiol. 2015 Jun 09; 65(22):2420-9
  4. Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003 Sep; 146(3):404-10
  5. Cheitlin MD, McAllister HA, de Castro CM. Myocardial infarction without atherosclerosis. JAMA. 1975 Mar 03; 231(9):951-9.
  6. Grinda JM, Couetil JP, Chauvaud S, D’Attellis N, Berrebi A, Fabiani JN, Deloche A, Carpentier A. Cardiac valve papillary fibroelastoma: surgical excision for revealed or potential embolization. J Thorac Cardiovasc Surg 1999; 117: 106–10.
  7. Chitwood WR Jr. Cardiac neoplasms: current diagnosis, pathology, and therapy. J Card Surg 1988; 3:119–154.
  8. Maleszewski JJ, Anavekar NS, Moynihan TJ, Klarich KW. Pathology, imaging, and treatment of cardiac tumours. Nat Rev Cardiol. 2017 Sep; 14(9):536-549
  9. Darvishian F, Farmer P. Papillary fibroelastoma of the heart: report of two cases and review of the literature. Ann Clin Lab Sci. 2001 Jul; 31(3):291-6
  10. Shanian DM. Papillary fibroelastomas. Semin Thorac Cardiovasc Surg. 2000; 1103:167–9.
  11. Howard RA, Aldea GS, Shapira OM, Kasznica JM, Davidoff R. Papillary fibroelastoma: increasing recognition of a surgical disease. Ann Thorac Surg. 1999; 68:1881–5.